ZenTech is a biotechnology company specializing in the development and commercialization of In Vitro solutions and reagents. Carried out non-invasively, the tests allow the detection of rare metabolic, genetic, chronic or infectious diseases on samples of human biological fluids.

Specializing in supporting patients from the early stages of life, ZenTech focuses resources on the development of a wide range of products for neonatal screening. The systematic screening carried out in all infants who are still asymptomatic makes it possible to detect the presence of serious and potentially treatable metabolic errors. This is the first essential step before any appropriate treatment is set up to ensure optimal development and quality of life for newborns.

Learn more